Vis enkel innførsel

dc.contributor.authorMartin-Kerry, Jacqueline
dc.contributor.authorTaylor, Jo
dc.contributor.authorScott, Sion
dc.contributor.authorPatel, Martyn
dc.contributor.authorWright, David John
dc.contributor.authorClark, Allan
dc.contributor.authorTurner, David
dc.contributor.authorAlldred, David Phillip
dc.contributor.authorMurphy, Katherine
dc.contributor.authorKeevil, Victoria
dc.contributor.authorWitham, Miles D.
dc.contributor.authorKellar, Ian
dc.contributor.authorBhattacharya, Debi
dc.date.accessioned2023-01-19T08:37:11Z
dc.date.available2023-01-19T08:37:11Z
dc.date.created2022-11-27T13:35:49Z
dc.date.issued2022
dc.identifier.issn0002-0729
dc.identifier.urihttps://hdl.handle.net/11250/3044463
dc.description.abstractBackground Half of older people are prescribed unnecessary/inappropriate medications that are not routinely deprescribed in hospital hence there is a need for deprescribing trials. We aimed to develop a Core Outcome Set (COS) for deprescribing trials for older people under the care of a geriatrician during hospital admission. Methods We developed a list of potentially relevant outcomes from the literature. Using a two-round Delphi survey of stakeholder groups representing older people and carers, hospital clinicians, hospital managers, and ageing/deprescribing researchers, each outcome was scored according to Grading of Recommendations Assessment, Development and Evaluation, followed by two consensus workshops to finalise the COS. Results Two hundred people completed Round 1 and 114 completed Round 2. Representing all stakeholder groups, 10 people participated in workshop 1 and 10 in workshop 2. Six outcomes were identified as most important, feasible and acceptable to collect in a trial: number of prescribed medicines stopped; number of prescribed medicines with dosage reduced; quality of life; mortality; adverse drug events and number of hospital stays. Three other outcomes were identified as important, but currently too burdensome to collect: number of potentially inappropriate medicines prescribed; burden from medication routine; and medication-related admissions to hospital. Conclusions A COS represents the minimum outcomes that should be collected and reported. Whilst uncommon practice for COS development, the value of considering outcome collection feasibility is demonstrated by the removal of three potential outcomes that, if included, may have compromised COS uptake due to challenges with collecting the data.en_US
dc.language.isoengen_US
dc.publisherOxford University Pressen_US
dc.rightsNavngivelse-Ikkekommersiell 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/deed.no*
dc.titleDeveloping a core outcome set for hospital deprescribing trials for older people under the care of a geriatricianen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2022 The Author(s)en_US
dc.source.articlenumberafac241en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2
dc.identifier.doi10.1093/ageing/afac241
dc.identifier.cristin2081770
dc.source.journalAge and Ageingen_US
dc.identifier.citationAge and Ageing. 2022, 51 (11), afac241.en_US
dc.source.volume51en_US
dc.source.issue11en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse-Ikkekommersiell 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse-Ikkekommersiell 4.0 Internasjonal